C12ORF49 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.120600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.058990E-01
Normal-vs-Stage2
4.089800E-01
Normal-vs-Stage3
4.298800E-01
Normal-vs-Stage4
4.006800E-01
Stage1-vs-Stage2
3.723000E-01
Stage1-vs-Stage3
9.878400E-01
Stage1-vs-Stage4
2.572600E-01
Stage2-vs-Stage3
4.593800E-01
Stage2-vs-Stage4
9.962600E-01
Stage3-vs-Stage4
6.481200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.972400E-01
Normal-vs-AfricanAmerican
9.977400E-01
Normal-vs-Asian
1.627240E-01
Caucasian-vs-AfricanAmerican
1.458400E-01
Caucasian-vs-Asian
8.085000E-01
AfricanAmerican-vs-Asian
1.358830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.706200E-01
Normal-vs-Female
1.214030E-01
Male-vs-Female
1.477550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.176800E-01
Normal-vs-Age(41-60Yrs)
5.704200E-01
Normal-vs-Age(61-80Yrs)
2.501600E-01
Normal-vs-Age(81-100Yrs)
1.213230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.369200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.246800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.042000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.181800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.814230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.099020E-01
Normal-vs-Daily Drinker
8.226100E-02
Normal-vs-Weekly Drinker
1.770390E-01
Normal-vs-Occasional Drinker
8.401800E-01
Normal-vs-Social Drinker
1.457560E-01
Non Drinker-vs-Daily Drinker
5.544200E-01
Non Drinker-vs-Weekly Drinker
8.688200E-01
Non Drinker-vs-Occasional Drinker
1.760560E-01
Non Drinker-vs-Social Drinker
6.221600E-01
Daily Drinker-vs-Weekly Drinker
7.629200E-01
Daily Drinker-vs-Occasional Drinker
1.075010E-01
Daily Drinker-vs-Social Drinker
3.260000E-01
Weekly Drinker-vs-Occasional Drinker
1.842000E-01
Weekly Drinker-vs-Social Drinker
5.871800E-01
Occasional Drinker-vs-Social Drinker
2.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.257200E-01
Normal-vs-Grade 2
6.864100E-02
Normal-vs-Grade 3
3.166200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.590100E-02
Grade 1-vs-Grade 3
1.555840E-01
Grade 1-vs-Grade 4
1.257200E-01
Grade 2-vs-Grade 3
3.145600E-01
Grade 2-vs-Grade 4
6.864100E-02
Grade 3-vs-Grade 4
3.166200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.276400E-01
Normal-vs-NonDiabetic
2.065000E-01
Diabetic-vs-NonDiabetic
6.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.328300E-02
Normal-vs-NoPancreatitis
3.141400E-01
Pancreatitis-vs-NoPancreatitis
2.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.054800E-01
Normal-vs-N1
3.481200E-01
N0-vs-N1
5.955600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.640000E-01
Normal-vs-TP53-NonMutant
3.568200E-01
TP53-Mutant-vs-TP53-NonMutant
5.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
